Kexian Li
Shanghai, 200433, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Low-dose ionizing radiation and cognitive function: evidence, mechanisms, and controversies.
Journal: Neuroscience
Published: April 24, 2026
LINC01137 facilitates pancreatic cancer stemness, chemoresistance and proliferation via the miR-7155-5p/KLF12/PI3K-Akt axis.
Journal: International journal of biological macromolecules
Published: October 19, 2025
Lysosome-escaping and nucleus-targeting nanomedicine for enhanced cancer catalytic internal radiotherapy.
Journal: European journal of nuclear medicine and molecular imaging
Published: November 12, 2024
TFAP2A enhances tumor stemness and promotes metastasis in pancreatic ductal adenocarcinoma.
Journal: iScience
Published: November 08, 2024
Low-dose-rate induces more severe cognitive impairment than high-dose-rate in rats exposed to chronic low-dose γ-radiation.
Journal: Frontiers in public health
Published: February 17, 2024
Chronic inhalation of H2S in low concentration induces immunotoxicity and inflammatory effects in lung tissue of rats.
Journal: Ecotoxicology and environmental safety
Published: December 27, 2023
Retraction Note: The LINC00623/NAT10 signaling axis promotes pancreatic cancer progression by remodeling ac4C modification of mRNA.
Journal: Journal of hematology & oncology
Published: November 01, 2023
The LINC00623/NAT10 signaling axis promotes pancreatic cancer progression by remodeling ac4C modification of mRNA.
Journal: Journal of hematology & oncology
Published: June 13, 2022
Development and Validation of a 7-Gene Prognostic Signature to Improve Survival Prediction in Pancreatic Ductal Adenocarcinoma.
Journal: Frontiers in molecular biosciences
Published: March 05, 2021
An EMT-Related Gene Signature for Predicting Response to Adjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma.
Journal: Frontiers in cell and developmental biology
Published: February 07, 2021
Transcriptomic Profiling Identifies DCBLD2 as a Diagnostic and Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma.
Journal: Frontiers in molecular biosciences
Published: January 27, 2021
Last Updated: 09/26/2026